Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dexian Zheng

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Molecular Biotechnology|May 5, 2009
Nucleic acids in protein samples interfere with phosphopeptide identification by immobilized-metal-ion affinity chromatography and mass spectrometryYaojun Li, Yuanming Luo, Shuzhen Wu, et al.
The FEBS Journal|January 6, 2009
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa BWanhu Tang, Weimin Wang, Yaxi Zhang, et al.
Molecular Cancer Therapeutics|October 17, 2007
Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activityChentao Lin, Wei Wei, Jinchun Zhang, et al.
Immunological Investigations|May 2, 2003
Tyrosine mutation in CD3epsilon-ITAM blocked T lymphocyte apoptosis mediated by CD3epsilonYanxin Liu, Yiping He, Jin Zhang, et al.
IUBMB Life|February 27, 2009
Death receptor 5-recruited raft components contributes to the sensitivity of Jurkat leukemia cell lines to TRAIL-induced cell deathYifan Min, Juan Shi, Yaxi Zhang, et al.
Life Sciences|May 20, 2008
AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in miceYing Zhang, Hong Ma, Jinchun Zhang, et al.
Immunology|October 15, 2013
TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesisJieqing Zhu, Longfei Chen, Juan Shi, et al.
Journal of Biochemistry|March 5, 2008
Erbin-regulated sensitivity of MCF-7 breast cancer cells to TRAIL via ErbB2/AKT/NF-kappaB pathwayNing Liu, Jindan Zhang, Jinchun Zhang, et al.
IUBMB Life|July 21, 2012
A novel anti-DR5 chimeric antibody and epirubicin synergistically suppress tumor growthYuhe Qiu, Zhixin Zhang, Juan Shi, et al.
Current Gene Therapy|July 23, 2003
Molecular therapeutics of HBVRuian Xu, Kexia Cai, Dexian Zheng, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Molecular Biotechnology|May 5, 2009
Nucleic acids in protein samples interfere with phosphopeptide identification by immobilized-metal-ion affinity chromatography and mass spectrometryYaojun Li, Yuanming Luo, Shuzhen Wu, et al.
The FEBS Journal|January 6, 2009
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa BWanhu Tang, Weimin Wang, Yaxi Zhang, et al.
Molecular Cancer Therapeutics|October 17, 2007
Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activityChentao Lin, Wei Wei, Jinchun Zhang, et al.
Immunological Investigations|May 2, 2003
Tyrosine mutation in CD3epsilon-ITAM blocked T lymphocyte apoptosis mediated by CD3epsilonYanxin Liu, Yiping He, Jin Zhang, et al.
IUBMB Life|February 27, 2009
Death receptor 5-recruited raft components contributes to the sensitivity of Jurkat leukemia cell lines to TRAIL-induced cell deathYifan Min, Juan Shi, Yaxi Zhang, et al.
Life Sciences|May 20, 2008
AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in miceYing Zhang, Hong Ma, Jinchun Zhang, et al.
Immunology|October 15, 2013
TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate-induced colitis and colitis-associated carcinogenesisJieqing Zhu, Longfei Chen, Juan Shi, et al.
Journal of Biochemistry|March 5, 2008
Erbin-regulated sensitivity of MCF-7 breast cancer cells to TRAIL via ErbB2/AKT/NF-kappaB pathwayNing Liu, Jindan Zhang, Jinchun Zhang, et al.
IUBMB Life|July 21, 2012
A novel anti-DR5 chimeric antibody and epirubicin synergistically suppress tumor growthYuhe Qiu, Zhixin Zhang, Juan Shi, et al.
Current Gene Therapy|July 23, 2003
Molecular therapeutics of HBVRuian Xu, Kexia Cai, Dexian Zheng, et al.
Pageof 7